June 30, 2025, expected to fund planned operations into 2028 EMERYVILLE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage ...

When organizations harness this kind of AI-powered insight, they stop treating scheduling as a static task and start managing ...

Refined exposure management cuts remediation by 96%, aligning security with business priorities for stronger, efficient ...